Computationally hybridized pathogenic mammarenavirus receptor binding domains reveal cryptic variants that elicit cross-neutralizing immune responses
Taylor, L.; Siman-Tov, G.; Ferrero, S.; Saito, T.; Helguera, G.; Maruyama, J.; Rodriguez, J. A.
Show abstract
The pathogenic mammarenaviruses, Machupo (MACV) and Junin (JUNV), are under evolutionary pressure to leverage human transferrin receptor 1 (hTfR1) for cellular entry while evading host immune responses during zoonosis. We now structurally and functionally investigate cryptic, computationally hybridized JUNV-MACV GP1 sequence variants. We then evaluate the ability of those variants to facilitate internalization of pseudotyped virus-like particles (PVs) into human cells and their recognition by neutralizing antibodies, including plasma from JUNV convalescent patients. We further compare the cryoEM structures of hTfR1-bound MACV GP1 to those of two functional hTfR1-bound MACV-JUNV hybrid GP1 variants that enable robust PV internalization and are also recognized by cross-neutralizing antibodies. Immunization with these variants demonstrates they and other hybrid GP1 sequences can elicit cross-reactive, neutralizing antibodies, supporting a model in which sequence adaptation within GP1 balances receptor recognition with immune evasion. This may inform the rational design of broadly neutralizing GP1-targeted antiviral therapies.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Structure guided mutagenesis of Henipavirus Receptor Binding Proteins reveals molecular determinants of receptor usage and antibody binding epitopes 96%
- A monoclonal antibody targeting the Nipah virus fusion glycoprotein apex imparts protection from disease 95%
- Differential recognition of computationally optimized H3 hemagglutinin influenza vaccine candidates by human antibodies 94%
Similar papers in this journal
- Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens 95%
- Structure selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concern 95%
- Structurally related but genetically unrelated antibody lineages converge on an immunodominantHIV-1 Env neutralizing determinant following trimer immunization 94%
Similar papers in this journal
- SARS-COV-2 Delta variant displays moderate resistance to neutralizing antibodies and spike protein properties of higher soluble ACE2 sensitivity, enhanced cleavage and fusogenic activity 94%
- Dynamics of SARS-CoV-2 VOC neutralization and novel mAb reveal protection against Omicron 93%
- Neutralization of SARS-CoV-2 Omicron BA.2 by Therapeutic Monoclonal Antibodies 92%
Similar papers in this journal
- Signatures of omicron-like adaptation in early SARS-CoV-2 variants and chronic infection 96%
- Antibody evasion and receptor binding of SARS-CoV-2 LP.8.1.1, NB.1.8.1, XFG, and related subvariants 95%
- Convergence of a common solution to broad ebolavirus neutralization by glycan cap directed human antibodies 95%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.